Cite

    Liu, F. et al. (n.d.). A favorable inductive remission rate for decitabine combined with chemotherapy as a first course in <60‐year‐old acute myeloid leukemia patients with myelodysplasia syndrome features. Cancer medicine. pp. 5108-5115. [Online].